MoneyWorks4Me

Eris Lifesciences - Quaterly Results

21 May 2026 Evaluate
The sales moved down -31.49% to Rs. 2773.10 millions for the March 2026 quarter as compared to Rs. 4047.70 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2026 is Rs. -86.00 millions as compared to Net Profit of Rs. 304.70 millions of corresponding quarter ended March 2025The company reported a degrowth in operating Profit to 487.50 millions from 1377.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 2773.10 4047.70 -31.49 18217.40 16977.50 7.30 18217.40 16977.50 7.30
Other Income 269.70 167.50 61.01 983.10 355.10 176.85 983.10 355.10 176.85
PBIDT 487.50 1377.20 -64.60 7106.40 5220.60 36.12 7106.40 5220.60 36.12
Interest 427.00 531.60 -19.68 1795.40 2202.40 -18.48 1795.40 2202.40 -18.48
PBDT 60.50 845.60 -92.85 5164.30 3018.20 71.11 5164.30 3018.20 71.11
Depreciation 388.20 433.80 -10.51 1543.80 1817.70 -15.07 1543.80 1817.70 -15.07
PBT -327.70 411.80 -179.58 3620.50 1200.50 201.58 3620.50 1200.50 201.58
TAX -241.70 107.10 -325.68 1180.00 426.60 176.61 1180.00 426.60 176.61
Deferred Tax -165.40 22.00 -851.82 570.40 206.80 175.82 570.40 206.80 175.82
PAT -86.00 304.70 -128.22 2440.50 773.90 215.35 2440.50 773.90 215.35
Equity 138.50 136.20 1.69 138.50 136.20 1.69 138.50 136.20 1.69
PBIDTM(%) 17.58 34.02 -48.33 39.01 30.75 26.86 39.01 30.75 26.86
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..